文献速递MDS 与骨髓增殖性肿瘤淋巴瘤白血病

PPM1D突变在血液系统肿瘤中的研究综述

Protein phosphatase, Mg2+/Mn2+-dependent 1D (PPM1D) mutations in haematological cancer.
PubMed 文献 · Br J Haematol · 2020-12-08

本文综述了蛋白磷酸酶PPM1D基因在血液系统肿瘤中的研究进展。PPM1D突变常见于克隆性造血(包括淋巴瘤、骨髓增殖性肿瘤和骨髓增生异常综合征患者),并与细胞毒及放疗暴露、治疗相关肿瘤发生和较差生存相关。突变多为无义或移码型,位于末端外显子6,在健康人血液中罕见。PPM1D编码WIP1磷酸酶,负调控DNA损伤反应通路(包括p53),其克隆扩增可能被抑制剂预防,但尚待人体试验。

要点

  • PPM1D突变常见于克隆性造血,与细胞毒/放疗暴露及治疗相关肿瘤相关。
  • 突变多为无义或移码型,位于末端外显子6,健康人血液中罕见。
  • PPM1D编码WIP1磷酸酶,负调控DNA损伤反应通路包括p53。

核心结论

  • PPM1D突变在血液系统肿瘤的克隆性造血中常见,与治疗暴露和不良生存相关,抑制剂预防克隆扩增尚待人体试验。

研究设计与样本

  • 本文为文献综述,检索范围未在摘要中明确报告。

主要发现

  • PPM1D突变常见于克隆性造血,包括淋巴瘤、骨髓增殖性肿瘤和骨髓增生异常综合征患者。
  • PPM1D突变与细胞毒和放疗暴露、治疗相关肿瘤发生及较差生存相关。
  • 绝大多数PPM1D突变为无义或移码型,位于末端外显子6,健康人血液中罕见。
  • PPM1D编码WIP1磷酸酶,负调控DNA损伤反应通路包括肿瘤抑制因子p53。
  • PPM1D突变造血细胞的克隆扩增可能被抑制剂预防,但人体试验尚待进行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Until recently, the protein phosphatase, Mg2+/Mn2+-dependent 1D (PPM1D) gene had not been examined in haematological cancer, but several studies have now explored the functional role of this gene and its aberrations. It is often mutated in the context of clonal haemopoiesis (including in patients with lymphoma, myeloproliferative neoplasms and myelodysplastic syndrome) and mutations have been associated with exposure to cytotoxic and radiation therapy, development of therapy-related neoplasms and inferior survival. The vast majority of PPM1D mutations found in haematopoietic cells are of the nonsense or frameshift type and located within terminal exon 6. These genetic defects are rarely found in the blood of healthy individuals. PPM1D encodes the PPM1D phosphatase [also named wild-type p53-induced phosphatase 1 (WIP1)], which negatively regulates signalling molecules within the DNA damage response pathway, including tumour suppressor p53. Clonal expansion of PPM1D mutant haematopoietic cells can potentially be prevented with inhibitors; however, human trials are awaited. In the present review, we provide a review of the literature regarding PPM1D and its role in haematological cancer.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Husby S, Hjermind Justesen E, Grønbæk K, et al. Protein phosphatase, Mg2+/Mn2+-dependent 1D (PPM1D) mutations in haematological cancer. Br J Haematol. 2020. PMID: 33616916. doi:10.1111/bjh.17120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。